Publications by authors named "Fanny Lalloyer"

Claim this Profile
T
The evolution of lipid-lowering drugs in the management of cardiovascular disease risk: From the first cardiovascular disease risk-reducing therapies to the novel challenging strategies.
Doriane Henry, Eric Baugé, Bart Staels, Fanny Lalloyer

Pharmacol Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in deficient mice.
Doriane Henry, Eric Baugé, Nathalie Hennuyer, Kevin Ory, Bruno Derudas, Fanny Lalloyer

Sci Transl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
Fanny Lalloyer, Denis A Mogilenko, Ann Verrijken, Joel T Haas, Antonin Lamazière

J Hepatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism.
Audrey Deprince, Nathalie Hennuyer, Sander Kooijman, Amanda C M Pronk, Eric Baugé, Fanny Lalloyer

Hepatology· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis.
Marie Bobowski-Gerard, Clémence Boulet, Francesco P Zummo, Julie Dubois-Chevalier, Céline Gheeraert, Fanny Lalloyer

Nat Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice.
Carmelo Quarta, Kerstin Stemmer, Aaron Novikoff, Bin Yang, Felix Klingelhuber, Fanny Lalloyer

Nat Metab· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity.
Francisco Sáez-Orellana, Thomas Leroy, Floriane Ribeiro, Anna Kreis, Karelle Leroy, Fanny Lalloyer

JCI Insight· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver.
Vanessa Dubois, Céline Gheeraert, Wouter Vankrunkelsven, Julie Dubois-Chevalier, Hélène Dehondt, Fanny Lalloyer

Mol Syst Biol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic PPARα is critical in the metabolic adaptation to sepsis.
Réjane Paumelle, Joel T Haas, Nathalie Hennuyer, Eric Baugé, Yann Deleye, Fanny Lalloyer

J Hepatol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-regulated gene dosage effect of PPARα on synaptic plasticity.
Nathalie Pierrot, Laurence Ris, Ilie-Cosmin Stancu, Anna Doshina, Floriane Ribeiro, Fanny Lalloyer

Life Sci Alliance· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin.
Philippe Lefebvre, Fanny Lalloyer, Eric Baugé, Michal Pawlak, Céline Gheeraert

JCI Insight· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency.
Michal Pawlak, Eric Baugé, Fanny Lalloyer, Philippe Lefebvre, Bart Staels

Mol Endocrinol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice.
Michal Pawlak, Eric Baugé, William Bourguet, Karolien De Bosscher, Fanny Lalloyer

Hepatology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites.
Michael Boergesen, Thomas Åskov Pedersen, Barbara Gross, Simon J van Heeringen, Dik Hagenbeek, Fanny Lalloyer

Mol Cell Biol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH.
Morgane Baron, Aurélie S Leroyer, Zouher Majd, Fanny Lalloyer, Emmanuelle Vallez

Atherosclerosis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
Fanny Lalloyer, Kristiaan Wouters, Morgane Baron, Sandrine Caron, Emmanuelle Vallez

Arterioscler Thromb Vasc Biol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrates, glitazones, and peroxisome proliferator-activated receptors.
Fanny Lalloyer, Bart Staels

Arterioscler Thromb Vasc Biol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver.
Fanny Lalloyer, Thomas Askov Pedersen, Barbara Gross, Sophie Lestavel, Saïd Yous

Arterioscler Thromb Vasc Biol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia.
Fanny Lalloyer, Catherine Fiévet, Sophie Lestavel, Gérard Torpier, Jelske van der Veen

Arterioscler Thromb Vasc Biol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets.
Fanny Lalloyer, Brigitte Vandewalle, Frédéric Percevault, Gérard Torpier, Julie Kerr-Conte

Diabetes· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis